Author's Posts

Emma Day

New Opiate Dosing Calculator for Health Care Providers

  • October 19, 2023
  • Emma Day

NEW RESOURCE AVAILABLE: This tool from the National Alliance of Sickle Cell Centers can help sickle cell providers make important decisions... Continue Reading

CMO Speaks: Gene Therapy for SCD (Part 2)

  • October 6, 2023
  • Emma Day

Welcome to CMO Speaks, a blog featuring the voices of SCDAA’s clinical leadership team. This is part two of a three-part... Continue Reading

MARAC Statement: Health Insurance Coverage for MSD SCT

  • September 22, 2023
  • Emma Day

MARAC Statement: Health Insurance Coverage for Hematopoietic Stem Cell Transplant for Sickle Cell Disease from HLA-matched Sibling Donor (MSD HCT) Sept.... Continue Reading

MARAC Statement: Update About COVID

  • September 22, 2023
  • Emma Day

Sept. 16, 2023 – The worldwide pandemic of COVID-19 (SARS-CoV2) infections seem to have settled down, and we are now seeing... Continue Reading

SCDAA and MedicAlert Foundation Launch Pilot Program

  • September 21, 2023
  • Emma Day

Leading Sickle Cell Organization and MedicAlert Foundation Launch Pilot Program to Improve Emergency Care During Sickle Cell Pain Crises Non-profits partner to... Continue Reading

Sickle Cell Awareness Month 2023 Events

  • August 28, 2023
  • Emma Day

All across the country, our member organizations are hosting exciting events for Sickle Cell Awareness Month this September. Check out the... Continue Reading

Abstracts Accepted Until 11:59 p.m. PST

  • July 17, 2023
  • Emma Day

This morning, we were notified that some users experienced issues using our 2023 National Abstract Competition portal. This issue has been... Continue Reading

MARAC Statement: Crizanlizumab (Adakveo)

  • July 7, 2023
  • Emma Day

July 7, 2023 – SCDAA’s Medical and Research Advisory Committee (MARAC) notes that the European Medicines Agency’s (EMA) Committee for Medicinal... Continue Reading

SCDAA Teams with MedicAlert Foundation

  • June 26, 2023
  • Emma Day

Sickle Cell Disease Association of America Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises Nonprofits partner to... Continue Reading

Afimmune joins the SCD C.A.R.E.S. Consortium

  • June 19, 2023
  • Emma Day

Dublin, Ireland, 19 June 2023: Afimmune, a clinical stage biopharmaceutical company developing novel rare disease therapeutics, today announced it has been invited to... Continue Reading